Association between H-RAS T81C genetic polymorphism with non-small cell Lung cancer

Y. Lee (Taichung, Taiwan), C. Shih (Taichung, Taiwan)

Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Session: Biological mechanisms of lung cancer
Session type: E-poster session
Number: 1760
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Lee (Taichung, Taiwan), C. Shih (Taichung, Taiwan). Association between H-RAS T81C genetic polymorphism with non-small cell Lung cancer. 1760

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Association of -93G®A polymorphism in the hMLH1 gene with susceptibility to and prognosis of non-small cell lung cancer in Taiwan
Source: Eur Respir J 2006; 28: Suppl. 50, 151s
Year: 2006

Association of Pre-miR-rs2910164 polymorphism with non-small cell lung cancer in an Iranian population
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018

Association of polymorphism of the human nm23-H1 gene (NME1) with susceptibility to and severity of non-small cell lung cancer
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007


MTHFR gene polymorphism in nonsmall cell lung cancer
Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Year: 2008


Association of XPD and CDA polymorphisms with clinical outcome in non-small cell lung cancer in a Chinese population
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

The association of cyclooxygenase 2 single-nucleotide polymorphisms with susceptibility to and severity of non-small cell lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015


Arg72Pro P53 gene polymorphism as a predisposing factor for non-small cell lung cancer (NSCLC) development
Source: Eur Respir J 2004; 24: Suppl. 48, 78s
Year: 2004

Investigation of survivin gene polymorphism in non-small cell lung cancer patients (NSCLC)
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012


Arg72Pro P53 gene polymorphism is associated with P53 mutations in non-small cell lung cancer (NSCLC) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 78s
Year: 2004

Association of genetic polymorphisms of matrix metalloproteinase (MMP)14 to the susceptibility of non-small cell lung cancer
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011


Analysis of XPD gene Lys751Gln polymorphism as predisposing factor for non-small cell lung cancer (NSCLC) development
Source: Eur Respir J 2007; 30: Suppl. 51, 131s
Year: 2007

Prognostic value of survivin gene promoter polymorphisms in non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016

The effects of polymorphisms identified in genome-wide association studies of never-smoking females on the prognosis of non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016

The significance of HSP90AA1, HSP90AB1 and HSP90B1 gene polymorphisms in a Turkish population with non-small cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Evaluation of EGFR mutations and ERCC2 polymorphisms in treatment of non-small cell lung cancer
Source: Annual Congress 2005 - Chemotherapy and palliative care
Year: 2005


The association of MMP-7 and MMP-13 genetic polymorphisms with susceptibility to non-small cell lung cancer in Taiwan
Source: Annual Congress 2008 - Biology in thoracic tumours
Year: 2008


Is MIF -173G/C polymorphism associated with in non-small cell lung cancer (NSCLC) susceptibility?
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010

A polymorphism, which exists intronic lesion of SLC5A10, affects DRG2 expression and survival outcome of early-stage non-small cell lung cancer
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015


Association between polymorphisms in microRNA target sites using CLASH data and survival of early-stage non-small cell lung cancer
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017


TP53 Arg72Pro, GSTM1, GSTP1 Ile105Val and GSTT1 gene polymorphisms as predisposing factors for non-small cell lung cancer (NSCLC) development
Source: Annual Congress 2006 - Molecular pathology and genetics of lung cancer
Year: 2006